Inventor · disambiguated record
Natasja Nielsen Viller
Also filed as: VILLER NATASJA NIELSEN
2 granted patents·7 pending applications·2 citations·filing 2017–2023
39Inventor score
Top patents by PatentIndex Score
9 records- 0165US2024018258A1Cd47 blockade therapy with cd38 antibodyPFIZER·Filed 2023·Application pending·0 cites
- 0264US11446315B2Enhancement of CD47 blockade therapy by proteasome inhibitorsPF ARGENTUM IP HOLDINGS LLC·Filed 2017·Granted Sep 20, 2022·2 cites·29 claims
- 0355US2023087443A1Enhancement of cd47 blockade therapy by proteasome inhibitorsPF ARGENTUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 0453US2025235504A1Enhancement of cd47 blockade with taxanes for cd47+ cancer therapyPFIZER·Filed 2022·Application pending·0 cites
- 0553US2021040224A1Cd47 blockade therapy with cd38 antibodyTRILLIUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0647US11779631B2CD47 blockade therapy by HDAC inhibitorsTrillium Therapeutics ULC·Filed 2017·Granted Oct 10, 2023·0 cites·17 claims
- 0744US2021040219A1Improvements in cd47 blockade therapy by egfr antibodyTRILLIUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0839US2020157179A1Cd47 blockade therapyTRILLIUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0937US2019091290A1Macrophage stimulation in cd47 blockade therapyTRILLIUM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Natasja Nielsen Viller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →